Zito J M, Craig T J, Wanderling J
Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962.
Am J Psychiatry. 1991 Jul;148(7):904-9. doi: 10.1176/ajp.148.7.904.
To determine the characteristics of cases of drug treatment refusal under the Rivers decision, which mandated court adjudication of such cases, the authors made a retrospective study of all applications for court review during 1 year in New York State inpatient facilities.
Sociodemographic and clinical characteristics of these 473 cases were compared with those of the 41,535 cases during the same period in which no court review was requested.
A 1% prevalence of applications requesting court review for nonemergency administration of medication over objection was found. The patients who refused medication were more likely than the comparison patients to have a crime-associated commitment status, a diagnosis of schizophrenia, and fewer previous hospital days, and they were more likely to be discharged. Medication refusers for whom applications for court review were submitted had relatively longer hospitalizations than the rest of the patients. Almost one-third of the applications submitted were withdrawn before court hearings, yielding a 0.7% prevalence of court-reviewed applications. Ninety-two percent of these applications for medication over objection were approved with virtually no change in the requested orders.
The study findings demonstrate that a front-end judicial determination of competency to refuse medication results in a time-consuming procedure which fails to ensure real due process or provide individualized alternative treatment. A two-tier system with in-house clinical review preceding judicial review is proposed to remedy the deficiencies of the current system.
为确定依据里弗斯裁决(该裁决规定此类案件需经法庭裁决)而拒绝药物治疗的病例特征,作者对纽约州住院机构1年内所有申请法庭审查的案例进行了回顾性研究。
将这473例案件的社会人口统计学和临床特征与同期41535例未申请法庭审查的案件进行比较。
发现因反对非紧急用药而申请法庭审查的比例为1%。拒绝用药的患者比对照患者更有可能具有与犯罪相关的强制住院状态、精神分裂症诊断、既往住院天数较少,且更有可能出院。提交法庭审查申请的拒药患者住院时间相对较长。提交的申请中近三分之一在法庭听证前撤回,经法庭审查的申请比例为0.7%。这些反对用药的申请中有92%被批准,所请求的医嘱几乎没有变化。
研究结果表明,对拒绝用药能力进行前端司法判定会导致程序耗时,无法确保真正的正当程序,也无法提供个性化的替代治疗。建议采用一个两级系统,在司法审查之前先进行内部临床审查,以弥补现行系统的不足。